|
1
|
Zakharia K, Luther CA, Alsabbak H and
Roberts LR: Hepatocellular carcinoma: Epidemiology, pathogenesis
and surveillance-implications for sub-Saharan Africa. S Afr Med J.
108:35–40. 2018.PubMed/NCBI
|
|
2
|
Kim WJ, Kim KH, Kim SH, Kang WH and Lee
SG: Laparoscopic versus open liver resection for centrally located
hepatocellular carcinoma in patients with cirrhosis: A propensity
score-matching analysis. Surg Laparosc Endosc Percutan Tech.
28:394–400. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xie W, Qiao X, Shang L, Dou J, Yang X,
Qiao S and Wu Y: Knockdown of ZNF233 suppresses hepatocellular
carcinoma cell proliferation and tumorigenesis. Gene. 679:179–185.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Abdel-Rahman O and Cheung WY: The
expanding role of systemic therapy in the management of
hepatocellular carcinoma. Can J Gastroenterol Hepatol.
2018:47638322018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tanaka H, Hijioka S, Iwaya H, Mizuno N,
Kuwahara T, Okuno N, Ito A, Kuraoka N, Matsumoto S, Obata M, et al:
Fibrolamellar hepatocellular carcinoma with multiple lung
metastases treated with multidisciplinary therapy. Intern Med.
57:3537–3543. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yoon SM, Ryoo BY, Lee SJ, Kim JH, Shin JH,
An JH, Lee HC and Lim YS: Efficacy and safety of transarterial
chemoembolization plus external beam radiotherapy vs. sorafenib in
hepatocellular carcinoma with macroscopic vascular invasion: A
randomized clinical trial. JAMA Oncol. 4:661–669. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Choi SH and Seong J: Strategic application
of radiotherapy for hepatocellular carcinoma. Clin Mol Hepatol.
24:114–134. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang PY, Chen MF, Tsai CH, Hu DN, Chang FR
and Wu YC: Involvement of caspase and MAPK activities in
norcantharidin-induced colorectal cancer cell apoptosis. Toxicol In
Vitro. 24:766–775. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Peng C, Liu X, Liu E, Xu K, Niu W, Chen R,
Wang J, Zhang Z, Lin P, Wang J, et al: Norcantharidin induces HT-29
colon cancer cell apoptosis through the alphavbeta6-extracellular
signal-related kinase signaling pathway. Cancer Sci. 100:2302–2308.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yeh CB, Hsieh MJ, Hsieh YH, Chien MH,
Chiou HL and Yang SF: Antimetastatic effects of norcantharidin on
hepatocellular carcinoma by transcriptional inhibition of MMP-9
through modulation of NF-kB activity. PLoS One. 7:e310552012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun CY, Zhu Y, Li XF, Tang LP, Su ZQ, Wang
XQ, Li CY, Yang HM, Zheng GJ and Feng B: Norcantharidin alone or in
combination with crizotinib induces autophagic cell death in
hepatocellular carcinoma by repressing c-Met-mTOR signaling.
Oncotarget. 8:114945–114955. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gao Y, Li W, Liu R, Guo Q, Li J, Bao Y,
Zheng H, Jiang S and Hua B: Norcantharidin inhibits IL-6-induced
epithelialmesenchymal transition via the JAK2/STAT3/TWIST signaling
pathway in hepatocellular carcinoma cells. Oncol Rep. 38:1224–1232.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bektas N, Noetzel E, Veeck J, Press MF,
Kristiansen G, Naami A, Hartmann A, Dimmler A, Beckmann MW, Knüchel
R, et al: The ubiquitin-like molecule interferon-stimulated gene 15
(ISG15) is a potential prognostic marker in human breast cancer.
Breast Cancer Res. 10:R582008. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hadjivasiliou A: ISG15 implicated in
cytoskeleton disruption and promotion of breast cancer. Expert Rev
Proteomics. 9:72012.
|
|
15
|
Tessema M, Yingling CM, Thomas CL, Klinge
DM, Bernauer AM, Liu Y, Dacic S, Siegfried JM, Dahlberg SE,
Schiller JH and Belinsky SA: SULF2 methylation is prognostic for
lung cancer survival and increases sensitivity to topoisomerase-I
inhibitors via induction of ISG15. Oncogene. 31:4107–4116. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Andersen JB, Aaboe M, Borden EC, Goloubeva
OG, Hassel BA and Orntoft TF: Stage-associated overexpression of
the ubiquitin-like protein, ISG15, in bladder cancer. Br J Cancer.
94:1465–1471. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qiu X, Hong Y, Yang D, Xia M, Zhu H, Li Q,
Xie H, Wu Q, Liu C and Zuo C: ISG15 as a novel prognostic biomarker
for hepatitis B virus-related hepatocellular carcinoma. Int J Clin
Exp Med. 8:17140–17150. 2015.PubMed/NCBI
|
|
18
|
Li C, Wang J, Zhang H, Zhu M, Chen F, Hu
Y, Liu H and Zhu H: Interferon-stimulated gene 15 (ISG15) is a
trigger for tumorigenesis and metastasis of hepatocellular
carcinoma. Oncotarget. 5:8429–8441. 2014.PubMed/NCBI
|
|
19
|
Desai SD, Wood LM, Tsai YC, Hsieh TS,
Marks JR, Scott GL, Giovanella BC and Liu LF: ISG15 as a novel
tumor biomarker for drug sensitivity. Mol Cancer Ther. 7:1430–1439.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li X, Zhao Q, Qi J, Wang W, Zhang D, Li Z
and Qin C: lncRNA Ftx promotes aerobic glycolysis and tumor
progression through the PPARγ pathway in hepatocellular carcinoma.
Int J Oncol. 53:551–566. 2018.PubMed/NCBI
|
|
21
|
Lin Q, Peng S and Yang Y: Inhibition of
CD9 expression reduces the metastatic capacity of human
hepatocellular carcinoma cell line MHCC97-H. Int J Oncol.
53:266–274. 2018.PubMed/NCBI
|
|
22
|
Kondo R, Ishino K, Wada R, Takata H, Peng
WX, Kudo M, Kure S, Kaneya Y, Taniai N, Yoshida H and Naito Z:
Downregulation of protein disulfideisomerase A3 expression inhibits
cell proliferation and induces apoptosis through STAT3 signaling in
hepatocellular carcinoma. INT J Oncol. 54:1409–1421.
2019.PubMed/NCBI
|
|
23
|
Tan X, Liao Z, Liang H, Chen X, Zhang B
and Chu L: Upregulation of liver kinase B1 predicts poor prognosis
in hepatocellular carcinoma. Int J Oncol. 53:1913–1926.
2018.PubMed/NCBI
|
|
24
|
Iwai N, Yasui K, Tomie A, Gen Y, Terasaki
K, Kitaichi T, Soda T, Yamada N, Dohi O, Seko Y, et al: Oncogenic
miR-96-5p inhibits apoptosis by targeting the caspase-9 gene in
hepatocellular carcinoma. Int J Oncol. 53:237–245. 2018.PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gu WJ and Liu HL: Induction of pancreatic
cancer cell apoptosis, invasion, migration, and enhancement of
chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by
hnRNP A2/B1 siRNA. Anticancer Drugs. 24:566–576. 2013.PubMed/NCBI
|
|
27
|
Liu T, Xiong J, Yi S, Zhang H, Zhou S, Gu
L and Zhou M: FKBP12 enhances sensitivity to chemotherapy-induced
cancer cell apoptosis by inhibiting MDM2. Oncogene. 36:1678–1686.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fang S, Qiu J, Wu Z, Bai T and Guo W:
Down-regulation of UBC9 increases the sensitivity of hepatocellular
carcinoma to doxorubicin. Oncotarget. 8:49783–49795. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Meng Q, He X, Xie G, Tian Q, Shu X, Li J
and Xiao Y: MEK inhibitor enhances sensitivity to chemotherapeutic
drugs in multidrug resistant hepatocellular carcinoma cells. Oncol
Lett. 14:3089–3095. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang QY, Yue XQ, Jiang YP, Han T and Xin
HL: FAM46C is critical for the anti-proliferation and pro-apoptotic
effects of norcantharidin in hepatocellular carcinoma cells. Sci
Rep. 7:3962017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang S, Li G, Ma X, Wang Y, Liu G, Feng
L, Zhao Y, Zhang G, Wu Y, Ye X, et al: Norcantharidin enhances
ABT-737-induced apoptosis in hepatocellular carcinoma cells by
transcriptional repression of Mcl-1. Cell Signal. 24:1803–1809.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xiong X, Wu M, Zhang H, Li J, Lu B, Guo Y,
Zhou T, Guo H, Peng R, Li X, et al: Atg5 siRNA inhibits autophagy
and enhances norcantharidin-induced apoptosis in hepatocellular
carcinoma. Int J Oncol. 47:1321–1328. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhao G, Zhu Y, Eno CO, Liu Y, Deleeuw L,
Burlison JA, Chaires JB, Trent JO and Li C: Activation of the
proapoptotic Bcl-2 protein Bax by a small molecule induces tumor
cell apoptosis. Mol Cell Biol. 34:1198–1207. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim B, Srivastava SK and Kim SH: Caspase-9
as a therapeutic target for treating cancer. Expert Opin Ther
Targets. 19:113–127. 2015. View Article : Google Scholar : PubMed/NCBI
|
